Please login to the form below

Not currently logged in
Email:
Password:

nab-paclitaxel

This page shows the latest nab-paclitaxel news and features for those working in and with pharma, biotech and healthcare.

Roche eyes September FDA verdict for triple NSCLC therapy

Roche eyes September FDA verdict for triple NSCLC therapy

The submission is based on the IMpower150 study, which combined Tecentriq with Avastin (bevacizumab) and the standard first-line NSCLC chemotherapy regimen paclitaxel/carboplatin and doubled the 12-month progression-free ... of carboplatin and

Latest news

More from news
Approximately 3 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics